Sou Hu Cai Jing·2025-09-01 12:27Financing Transactions - Meikaman's recent financing round raised nearly 500 million yuan, with investments from various funds including Xiong'an Fund and Ocean Electric, aimed at advancing its embodied intelligence technology and expanding product lines and applications [3] - Ruizheng Gene secured $75 million in Series A funding, with a significant investment from Tibet Nodi Kang Pharmaceutical, to develop in vivo gene editing products [4][6] - Weijian Intelligent completed over 100 million yuan in Series B funding, focusing on R&D for advanced packaging equipment for AI applications [4][5] - Wuxi Xinxiang Technology announced several billion yuan in B+ round financing, showcasing strong recognition from state-owned capital for its technological capabilities [6] - Haojise Food received strategic investments totaling several billion yuan from the Bubugao Group, aimed at enhancing product development and supply chain systems [6] - Yingmou Technology completed a new round of financing worth tens of millions of dollars, with plans to launch a new model on its 3D generation platform [7] - Lingyu Intelligent raised millions in seed+ round financing, focusing on high-quality remote operation technology for service and industrial applications [8] - Wugen, a US-based T-cell cancer treatment provider, raised $115 million to advance its cell therapy for T-cell acute lymphoblastic leukemia [8] - Prologis GLP received a $1.5 billion investment from Abu Dhabi Investment Authority to support its growth in logistics infrastructure [9] - Blue Water, an autonomous vessel developer, secured $50 million in Series A funding led by Google Ventures [10]